The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction | Molecular Biology of Disease
The EMBO Journal (2005) 24, 73–84, doi:10.1038/sj.emboj.7600460
Published online 9 December 2004
FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development
Mario N Chamorro1, 4, Donald R Schwartz2, 5, Alin Vonica3, 5, Ali H Brivanlou3, Kathleen R Cho2 and Harold E Varmus1
1 Cancer Biology and Genetics Program, Sloan-Kettering Institute, Varmus Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
2 Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI, USA
3 The Laboratory of Vertebrate Embryology, The Rockefeller University, New York, NY, USA
4 Cell Biology Program, Cornell University, Weill Graduate School of Medical Sciences, New York, NY, USA

To whom correspondence should be addressed
Harold E Varmus, Cancer Biology and Genetics Program, Sloan-Kettering Institute, Varmus Laboratory-RRL717, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 62, New York, NY 10021, USA. Tel.: +1 212 639 6561; Fax: +1 212 717 3125; E-mail: varmus@mskcc.org

5 These authors contributed equally to this work

Received 4 June 2004; Accepted 6 October 2004; Published online 9 December 2004.
Abstract
beta-catenin is the major effector of the canonical Wnt signaling pathway. Mutations in components of the pathway that stabilize beta-catenin result in augmented gene transcription and play a major role in many human cancers. We employed microarrays to identify transcriptional targets of deregulated beta-catenin in a human epithelial cell line (293) engineered to produce mutant beta-catenin and in ovarian endometrioid adenocarcinomas characterized with respect to mutations affecting the Wnt/beta-catenin pathway. Two genes strongly induced in both systems—FGF20 and DKK1—were studied in detail. Elevated levels of FGF20 RNA were also observed in adenomas from mice carrying the ApcMinallele. Both XFGF20 and Xdkk-1 are expressed early in Xenopus embryogenesis under the control of the Wnt signaling pathway. Furthermore, FGF20 and DKK1 appear to be direct targets for beta-catenin/TCF transcriptional regulation via LEF/TCF-binding sites. Finally, by using small inhibitory RNAs specific for FGF20, we show that continued expression of FGF20 is necessary for maintenance of the anchorage-independent growth state in RK3E cells transformed by beta-catenin, implying that FGF-20 may be a critical element in oncogenesis induced by the Wnt signaling pathway.
Keywords: beta-catenin, DKK1, FGF-20, Wnt signaling, Xenopus laevis
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2005 by the European Molecular Biology Organization